oral-child TDLo 19 mg/kg/4W-I PERIPHERAL NERVE AND SENSATION: FASCICULATIONS Pediatrics. Vol. 73, Pg. 841, 1984.
oral-child TDLo 25926 ug/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 35, Pg. 320, 1993.
oral-child TDLo 55 mg/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: COMA Journal of Toxicology, Clinical Toxicology. Vol. 38, Pg. 323, 2000.
oral-child TDLo 65 mg/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: COMA Journal of Pediatrics. Vol. 121, Pg. 295, 1992.
oral-child TDLo 420 mg/kg/3W-I BEHAVIORAL: GENERAL ANESTHETIC
BEHAVIORAL: TREMOR
SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE Journal of Toxicology, Clinical Toxicology. Vol. 36, Pg. 109, 1998.
oral-child TDLo 1050 mg/kg/6W- BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) American Journal of Psychiatry. Vol. 143, Pg. 1176, 1985.
oral-dog LD50 5620 mg/kg "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 63, 1972.
oral-guinea pig LD50 920 mg/kg "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 63, 1972.
oral-human TDLo 43 mg/kg BEHAVIORAL: SLEEP
BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"
GASTROINTESTINAL: NAUSEA OR VOMITING British Medical Journal. Vol. 1, Pg. 754, 1977.
oral-man LDLo 54 mg/kg/9D-I BLOOD: AGRANULOCYTOSIS
KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED
BEHAVIORAL: ATAXIA Canadian Medical Association Journal. Vol. 132, Pg. 1040, 1985.
oral-man TDLo 94 mg/kg/11D-I BLOOD: THROMBOCYTOPENIA Journal of Clinical Pyschopharmacology. Vol. 10, Pg. 305, 1990.
oral-man TDLo 160 mg/kg/3W-I SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" Journal of Clinical Pyschopharmacology. Vol. 5, Pg. 185, 1985.
oral-man TDLo 253 mg/kg/6W-I GASTROINTESTINAL: NAUSEA OR VOMITING
LIVER: LIVER FUNCTION TESTS IMPAIRED Journal of Clinical Pyschopharmacology. Vol. 6, Pg. 251, 1986.
intraperitoneal-mouse LD50 114 mg/kg Farmakologiya i Toksikologiya Vol. 53(4), Pg. 19, 1990.
oral-mouse LD50 529 mg/kg Farmaco. Vol. 44, Pg. 595, 1989.
oral-rabbit LD50 2680 mg/kg "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 63, 1972.
intraperitoneal-rat LD50 158 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. Vol. 202, Pg. 106, 1973.
oral-rat LD50 1957 mg/kg BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) Japanese Kokai Tokyo Koho Patents. Vol. #79-163823
|